Your browser doesn't support javascript.
loading
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Thieblemont, Catherine; Howlett, Susannah; Casasnovas, René-Olivier; Mounier, Nicolas; Perrot, Aurore; Morschhauser, Franck; Fruchart, Christophe; Daguindau, Nicolas; van Eygen, Koen; Obéric, Lucie; Bouabdallah, Reda; Pica, Gian Matteo; Nicolas-Virezelier, Emmanuelle; Abraham, Julie; Fitoussi, Olivier; Snauwaert, Sylvia; Eisenmann, Jean-Claude; Lionne-Huyghe, Pauline; Bron, Dominique; Tricot, Sabine; Deeren, Dries; Gonzalez, Hugo; Costello, Régis; Le Du, Katell; da Silva, Maria Gomes; Grosicki, Sebastian; Trotman, Judith; Catalano, John; Caballero, Dolores; Greil, Richard; Cohen, Amos M; Gaulard, Philippe; Roulin, Louise; Takeshita, Kenichi; Casadebaig, Marie-Laure; Tilly, Hervé; Coiffier, Bertrand.
Afiliación
  • Thieblemont C; Hemato-Oncology, APHP, Hôpital Saint-Louis, Paris, France.
  • Howlett S; Celgene Corporation, Summit, NJ, USA.
  • Casasnovas RO; Service d'Hématologie Clinique, Centre Hospitalier Universitaire de Dijon and INSERM UMR1231, Dijon, France.
  • Mounier N; Hématologie, Centre Hospitalier Universitaire de Nice - Hôpital de l'Archet, Nice, France.
  • Perrot A; Service d'Hématologie, Centre Hospitalier Universitaire de Nancy, Nancy, France.
  • Morschhauser F; Institute of Hematology-Transfusion, Centre Hospitalier Universitaire Régional de Lille, Lille, France.
  • Fruchart C; Service d'Hématologie, Institut d'Hématologie de Basse-Normandie, Centre Hospitalier Universitaire de Caen, Caen, France.
  • Daguindau N; Service d'Hématologie Clinique, Centre Hospitalier Annecy Genevois, Annecy, France.
  • van Eygen K; Oncologisch Centrum, AZ Groeninge Hospital, Kortrijk, Belgium.
  • Obéric L; Hôpital de Purpan, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Bouabdallah R; Department of Hematology, Institut Paoli Calmettes, Marseille, France.
  • Pica GM; Centre Hospitalier de Metropole Savoie, Chambery, France.
  • Nicolas-Virezelier E; Cancer Research Center of Lyon, Lyon, France.
  • Abraham J; Centre Hospitalier Universitaire Dupuytren, Limoges, France.
  • Fitoussi O; Hematology/Oncology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France.
  • Snauwaert S; AZ Sint-Jan Brugge-Oostende, Bruges, Belgium.
  • Eisenmann JC; Centre Hospitalier de Mulhouse, Mulhouse, France.
  • Lionne-Huyghe P; Centre Hospitalier d'Arras, Arras, France.
  • Bron D; Institut Jules Bordet, Brussels, Belgium.
  • Tricot S; Centre Hospitalier de Valenciennes, Valenciennes, France.
  • Deeren D; AZ Delta, Roeselare, Belgium.
  • Gonzalez H; Centre Hospitalier René-Dubos, Pontoise, France.
  • Costello R; Hôpital de la Conception, Marseille, France.
  • Le Du K; Clinique Victor Hugo, Le Mans, France.
  • da Silva MG; Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.
  • Grosicki S; Medical University of Silesia, Katowice, Poland.
  • Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.
  • Catalano J; Frankston Hospital and Monash University, Frankston, Vic., Australia.
  • Caballero D; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Greil R; Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Salzburg, Austria.
  • Cohen AM; Rabin Medical Center, Beilinson Hospital, Davidoff Cancer Center, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.
  • Gaulard P; University Hospital Henri Mondor APHP, Créteil, France.
  • Roulin L; Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Créteil, France.
  • Takeshita K; Celgene Corporation, Summit, NJ, USA.
  • Casadebaig ML; Celgene Corporation, Boudry, Switzerland.
  • Tilly H; Department of Hematology, Centre Henri Becquerel, UNIROUEN, INSERMU1245, Rouen, France.
  • Coiffier B; Department of Hematology, INSERM U1052 Hospices Civils de Lyon, Pierre-Bénite, France.
Br J Haematol ; 189(1): 84-96, 2020 04.
Article en En | MEDLINE | ID: mdl-31702836
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Quimioterapia de Mantención / Lenalidomida Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Quimioterapia de Mantención / Lenalidomida Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: Francia